The estimated Net Worth of Genetic Disorder L.P.Robert... is at least $1.03 Миллиард dollars as of 1 July 2019. Genetic Robert owns over 2,647,100 units of BridgeBio Pharma Inc stock worth over $1,032,849,501 and over the last 5 years Genetic sold BBIO stock worth over $0.
Genetic has made over 1 trades of the BridgeBio Pharma Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Genetic bought 2,647,100 units of BBIO stock worth $45,000,700 on 1 July 2019.
The largest trade Genetic's ever made was buying 2,647,100 units of BridgeBio Pharma Inc stock on 1 July 2019 worth over $45,000,700. On average, Genetic trades about 2,647,100 units every 0 days since 2019. As of 1 July 2019 Genetic still owns at least 36,900,661 units of BridgeBio Pharma Inc stock.
You can see the complete history of Genetic Robert stock trades at the bottom of the page.
Over the last 5 years, insiders at BridgeBio Pharma Inc have traded over $409,396,563 worth of BridgeBio Pharma Inc stock and bought 12,280,644 units worth $209,241,115 . The most active insiders traders include Global Investors Lp Viking ..., Andrew Lo и Genetic Disorder L.P.Kkr Ge.... On average, BridgeBio Pharma Inc executives and independent directors trade stock every 12 days with the average trade being worth of $4,173,197. The most recent stock trade was executed by Neil Kumar on 16 August 2024, trading 55,537 units of BBIO stock currently worth $1,554,481.
we focus on accelerating and maximizing value in early-stage, genetic disease assets by applying our management expertise and proprietary platform. our team picks the right assets based on our systematic mapping of the genetic disease landscape, and develops those assets with the right approach, supporting r&d with expert capabilities and placing them in a value maximizing corporate structure.
BridgeBio Pharma Inc executives and other stock owners filed with the SEC include: